Ocuphire eye drop Nyxol for reversing pupil dilation meets main goal in 2nd phase 3 trial
March 29 2022 - 7:18AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Ocuphire Pharma (NASDAQ:OCUP)
Historical Stock Chart
From Apr 2024 to May 2024
Ocuphire Pharma (NASDAQ:OCUP)
Historical Stock Chart
From May 2023 to May 2024